The involvement of Eli Lilly shows that big pharma are interested and consider encapsulation a valid area for their investment.
Which is great for us.
Now they have committed to it others should follow rather than let Eli Lilly take the whole cake.
A non alginate encapsulation is better as it has many advantages. And ours has been tested in humans and remained active for two years as it had very low immune response. That’s a huge plus.
Don’t you think other big pharma will be looking at this area now too.
Is this why stem cells producing insulin were added to the new Austrianova agreement?
How long will it be before big pharma wants the best cell encapsulation technology which has already been tested in humans?
News 
Market Data 
Discover 
AI
